Paper16733337
Olfactory disorders following upper respiratory tract infections.
Welge-Lüssen A and 1 other. Adv Otorhinolaryngol, 2006. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Olfactory disorders following upper respiratory tract infections. Papers, record 16733337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16733337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Olfaction Disorders | Major topic |
| Respiratory Tract Infections | Major topic |
| Humans | |
| Olfactory Mucosa | |
| Prognosis |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT05445921 | Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction | Background | ClinicalTrials.gov | |
| NCT06498687 | Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia | Background | ClinicalTrials.gov |
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41170265 | Effects of Toki Shakuyaku San on Olfactory Function in a Postmenopausal Mouse Model. | Cureus | 2025 | https://conductscience.org/library/papers/41170265 | PubMed |
| 39464360 | Treatments for Olfactory Dysfunction in COVID-19: A Systematic Review. | Int Arch Otorhinolaryngol | 2024 | https://conductscience.org/library/papers/39464360 | PubMed |
| 39160183 | Association of olfactory and cognitive function test scores with hippocampal and amygdalar grey matter volume: a cross-sectional study. | Sci Rep | 2024 | https://conductscience.org/library/papers/39160183 | PubMed |
| 38903957 | Structures and functions of the normal and injured human olfactory epithelium. | Front Neural Circuits | 2024 | https://conductscience.org/library/papers/38903957 | PubMed |
| 38855291 | Recovery rates and long-term olfactory dysfunction following COVID-19 infection. | World J Otorhinolaryngol Head Neck Surg | 2024 | https://conductscience.org/library/papers/38855291 | PubMed |
| 38620197 | [Olfactory dysfunction in COVID-19, a review of the evidence and implications for pandemic management]. | Acta Otorrinolaringol Esp | 2020 | https://conductscience.org/library/papers/38620197 | PubMed |
| 38543591 | SARS-CoV-2 and Other Respiratory Viruses in Human Olfactory Pathophysiology. | Microorganisms | 2024 | https://conductscience.org/library/papers/38543591 | PubMed |
| 38212781 | The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults. | Virol J | 2024 | https://conductscience.org/library/papers/38212781 | PubMed |
| 38097777 | Olfactory immunology: the missing piece in airway and CNS defence. | Nat Rev Immunol | 2024 | https://conductscience.org/library/papers/38097777 | PubMed |
| 37894169 | SARS-CoV-2 and Brain Health: New Challenges in the Era of the Pandemic. | Microorganisms | 2023 | https://conductscience.org/library/papers/37894169 | PubMed |
| 37841969 | Post-viral olfactory loss and parosmia. | BMJ Med | 2023 | https://conductscience.org/library/papers/37841969 | PubMed |
| 37568409 | Heterogeneous Damage to the Olfactory Epithelium in Patients with Post-Viral Olfactory Dysfunction. | J Clin Med | 2023 | https://conductscience.org/library/papers/37568409 | PubMed |
| 36517057 | The incidence and impact of anosmia on daily life after COVID-19 infection: A cross-sectional study in a tertiary center in Saudi Arabia. | Saudi Med J | 2022 | https://conductscience.org/library/papers/36517057 | PubMed |
| 36339652 | Störungen des Riech- und Schmeckvermögens bei COVID-19. | Allergo J | 2022 | https://conductscience.org/library/papers/36339652 | PubMed |
| 35772604 | Nervous system manifestations related to COVID-19 and their possible mechanisms. | Brain Res Bull | 2022 | https://conductscience.org/library/papers/35772604 | PubMed |
| 35755859 | Olfactory and gustatory disorders in COVID-19. | Allergo J Int | 2022 | https://conductscience.org/library/papers/35755859 | PubMed |
| 35447981 | Pathogenesis of Olfactory Disorders in COVID-19. | Brain Sci | 2022 | https://conductscience.org/library/papers/35447981 | PubMed |
| 35318656 | Neuroradiological Basis of COVID-19 Olfactory Dysfunction: A Systematic Review and Meta-Analysis. | Laryngoscope | 2022 | https://conductscience.org/library/papers/35318656 | PubMed |
| 35307631 | Neurological Evaluation of Geriatric Patients Being Treated for COVID-19. | Eurasian J Med | 2022 | https://conductscience.org/library/papers/35307631 | PubMed |
| 35249186 | "Anosmia" the mysterious collateral damage of COVID-19. | J Neurovirol | 2022 | https://conductscience.org/library/papers/35249186 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16733337
GET https://conductscience.org/api/papers/v1/16733337/cited_by?page=2